In this week's podcast we'll discuss another step forward in stamping out high-risk myeloma. Then we'll hear about the plasmin-cleaved von Willebrand factor, or VWF, in microthrombosis. Finally we'll hear about new insights into the origins of sickle cell pain.
Featured Articles:
- Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly
diagnosed myeloma - Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis
- Sickle cell disease iPSC-derived sensory neurons exhibit increased excitability and sensitization to patient
plasma
Fler avsnitt av Blood Podcast
Visa alla avsnitt av Blood PodcastBlood Podcast med American Society of Hematology finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
